Skip to main content

Table 4 Treatment data

From: Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

  SE Region
Occurrence of dose reduction
 Gemcitabine 60 (80)
 Nab-Paclitaxel 60 (80)
Reason given for dose reduction
 Neutropenia 23 (26)
 Comorbidity 13 (15)
 Infection 11 (12)
 Neuropathy 11 (12)
 Thrombocytopenia 8 (9)
 Liver toxicity 6 (7)
 Anaemia 5 (6)
  1. Dose reduction and reasons for dose reduction, n(%) where not else stated. SE South Eastern Region of Sweden
\